Literature DB >> 16271852

Increased responsiveness to MDMA in adult rats treated neonatally with MDMA.

Brian J Piper1, Jerrold S Meyer.   

Abstract

MDMA [(+/-)3,4-methylenedioxymethamphetamine, also known as ecstasy] is a popular recreational drug among women of reproductive age. The objective of this study was to investigate the long-term neurobehavioral consequences of early developmental MDMA exposure. On postnatal days (PD) 1-4, Sprague-Dawley rats received two 10 mg/kg injections of MDMA with an inter-dose interval of 4 h. Male subjects were tested in adulthood for their performance in an object-recognition memory task and for their thermal and behavioral responses to an acute MDMA challenge (10 mg/kg i.p.). Neonatal MDMA administration did not alter working memory in the object-recognition test in young adulthood (PD 68-73) and there were no differences in radiolabeled citalopram binding to the serotonin transporter at this age. However, the pretreated animals showed increased thermal dysregulation and serotonin syndrome responses (particularly headweaving stereotypy) following the MDMA challenge. These results add to the growing literature demonstrating that developmental MDMA administration can lead to long-lasting functional abnormalities, and they further suggest that the offspring of ecstasy-using women may be at risk for enhanced sensitivity to this drug due to their earlier exposure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16271852     DOI: 10.1016/j.ntt.2005.09.002

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  6 in total

Review 1.  A developmental comparison of the neurobehavioral effects of ecstasy (MDMA).

Authors:  Brian J Piper
Journal:  Neurotoxicol Teratol       Date:  2006-10-20       Impact factor: 3.763

Review 2.  Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Authors:  Emily J Ross; Devon L Graham; Kelli M Money; Gregg D Stanwood
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

3.  Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats.

Authors:  Erica Y Shen; Syed F Ali; Jerrold S Meyer
Journal:  Neuropharmacology       Date:  2011-07-13       Impact factor: 5.250

Review 4.  Developmental effects of 3,4-methylenedioxymethamphetamine: a review.

Authors:  Matthew R Skelton; Michael T Williams; Charles V Vorhees
Journal:  Behav Pharmacol       Date:  2008-03       Impact factor: 2.293

5.  Behavioral, thermal and neurochemical effects of acute and chronic 3,4-methylenedioxymethamphetamine ("Ecstasy") self-administration.

Authors:  Maria Elena Reveron; Esther Y Maier; Christine L Duvauchelle
Journal:  Behav Brain Res       Date:  2009-11-03       Impact factor: 3.332

6.  The Nature of 3, 4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonergic Dysfunction: Evidence for and Against the Neurodegeneration Hypothesis.

Authors:  Dominik K Biezonski; Jerrold S Meyer
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.